MUSCLE STRENGTH IMBALANCE AND KINESIOPHOBIA IN MENISCUS PATIENTS (NCT07407075) | Clinical Trial Compass
CompletedNot Applicable
MUSCLE STRENGTH IMBALANCE AND KINESIOPHOBIA IN MENISCUS PATIENTS
Turkey (Türkiye)46 participantsStarted 2026-02-06
Plain-language summary
This study is a cross-sectional and comparative clinical investigation designed to examine the relationship between periarticular muscle strength imbalance and kinesiophobia levels in individuals with meniscal injuries receiving postoperative or conservative treatment, and to determine whether this relationship differs according to the treatment modality.
Who can participate
Age range
18 Years – 50 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Being between 18 and 50 years of age, with a diagnosis of meniscal injury (male or female)
* Having a medial meniscal injury confirmed by magnetic resonance imaging (MRI)
* Presence of a unilateral injury
* Voluntary agreement to participate in the study
* A minimum of 3 weeks having elapsed since surgery for postoperative participants
* A minimum of 2 months having elapsed since injury for participants receiving conservative treatment
Exclusion Criteria:
* Concomitant anterior cruciate ligament (ACL) injury or additional ligament injuries such as posterior cruciate ligament (PCL), lateral collateral ligament (LCL), or medial collateral ligament (MCL)
* History of fracture or significant trauma to the lower extremity within the past 6 months
* Current or previous neurological disorders (e.g., stroke, multiple sclerosis, peripheral neuropathy, Parkinson's disease)
* Vestibular system disorders or any conditions affecting balance
* Presence of a second surgical intervention or postoperative complications
* Osteoarthritis with a Kellgren-Lawrence grade ≥ 2
* Contracture or severe limitation of knee range of motion restricting joint mobility
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Muscle Strength
Timeframe: Baseline. The assessment will be conducted once during the study period.
2
Tampa Kinesiophobia Scale (TKS-17)
Timeframe: Baseline. The evaluation is conducted only once during the research process.